BMS-986168 ( DrugBank: BMS-986168 )

1 disease

ID	Disease name (Link within this page)	Number of trials
5	Progressive supranuclear palsy	4

5. Progressive supranuclear palsy

Clinical trials : 89 / Drugs : 107 - (DrugBank : 40) / Drug target genes : 65 - Drug target pathways : 108

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-173627	01/8/2017	26/06/2017	Study of BMS-986168 in Patients With Progressive Supranuclear Palsy (PASSPORT)	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Sa ...	Progressive Supranuclear Palsy	Intervention name : BMS-986168 Dosage And administration of the intervention : BMS-986168intravenous ...	Bristol-Myers Squibb K.K.	NULL		41	86	BOTH	396	Phase 2	NULL
2	EUCTR2016-002554-21-ES (EUCTR)	08/06/2017	24/04/2017	A study to test the effectiveness and safety of test product BMS-986168compared to placebo in partic ...	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Sa ...	Progressive supranuclear palsy MedDRA version: 19.1;Level: PT;Classification code 10036813;Term: Pro ...	Product Code: BMS-986168 INN or Proposed INN: BMS986168 Other descriptive name: BMS986168	Bristol-Myers Squibb International Corporation	NULL	Not Recruiting			Female: yes Male: yes	396	Phase 2	United States;Greece;Spain;Austria;Russian Federation;Italy;United Kingdom;France;Canada;Australia;G ...
3	NCT02460094 (ClinicalTrials.gov)	October 2, 2015	20/5/2015	Multiple Ascending Dose Study of Intravenously Administered BMS-986168(BIIB092) in Patients With Pro ...	A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Intravenously Admin ...	Progressive Supranuclear Palsy	Drug: BIIB092;Drug: Placebo	Biogen	NULL	Completed	41 Years	86 Years	All	48	Phase 1	United States
4	EUCTR2016-002554-21-FR (EUCTR)		15/06/2018	A study to test the effectiveness and safety of test product BMS-986168compared to placebo in partic ...	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Sa ...	Progressive supranuclear palsy MedDRA version: 20.0;Level: PT;Classification code 10036813;Term: Pro ...	Product Code: BMS-986168 INN or Proposed INN: BMS986168 Other descriptive name: BMS986168	Bristol-Myers Squibb International Corporation	NULL	NA			Female: yes Male: yes	396	Phase 2	United States;Greece;Spain;Austria;Russian Federation;United Kingdom;Italy;France;Canada;Australia;G ...

First Previous1Next Last